Kubota Pharmaceutical Holdings

4596.TTSE GROWTHPharmaceutical

Key numbers · FY ended 2025-12

Revenue¥21m-21.5% YoY Operating income−¥895m—Net income (owners)−¥676m—Total assets¥2.0bn+28.4% YoY EPS (basic)¥-10.59+55.2% YoY

Full financial history and reports →

Stock price4596 · View chart ↗

Open the price chart on TradingView.

Latest filings

Tue, Oct 13 · JST3 filings

12:11MATERIALKubota Pharmaceutical Holdings · Change in major shareholder 12:08MATERIALKubota Pharmaceutical Holdings · Change in major shareholder 12:04MATERIALKubota Pharmaceutical Holdings · Change of independent auditor

Tue, Jul 14 · JST1 filing

11:425% STAKEKubota Pharmaceutical Holdings · Evo Fund + 1 joint holder · 8.19% → 4.32%−3.87pp

Wed, Jul 8 · JST1 filing

12:565% STAKEKubota Pharmaceutical Holdings · Evo Fund + 1 joint holder · 6.18% → 8.19%+2.01pp

All filings →

Major holders (5%+) · 2

Holder	Stake	Change	Filed
Ryo Kubota	41.41%	+10.84pp	2025-12-23
Kubota Asset Management Co., Ltd.	12.38%	—	2025-12-23

Each holder's own ratio from its most recent large-shareholding report.